drugset / Trial / NCT02495662
The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation
Phase 2
Terminated
30 enrolled
Leiden University Medical Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · collabAlrijne Hospital · collabHagaZiekenhuis · collabMedical Center Haaglanden · collabOLVG · collabReinier de Graaf Groep · collabSpaarne Gasthuis · collabTergooi Ziekenhuis · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will investigate if liposomal prednisolone is effective in promoting arteriovenous fistula (AVF) maturation when administered to human subjects after surgical creation of a radio-cephalic AVF.
Timeline
- Start
- 2015-11
- Primary completion
- 2018-05-30
- Completion
- 2018-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisolone | Other / unclassified | 150 mg | Intravenous |
Indications
No indication recorded.